{"id":"https://openalex.org/W4200544627","doi":"https://doi.org/10.1111/cts.13221","title":"Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes","display_name":"Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes","publication_year":2021,"publication_date":"2021-12-28","ids":{"openalex":"https://openalex.org/W4200544627","doi":"https://doi.org/10.1111/cts.13221","pmid":"https://pubmed.ncbi.nlm.nih.gov/34962074","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9010270"},"language":"en","primary_location":{"id":"doi:10.1111/cts.13221","doi":"https://doi.org/10.1111/cts.13221","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13221","pdf_url":null,"source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1111/cts.13221","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050010032","display_name":"Yoshiko Tomita","orcid":"https://orcid.org/0000-0001-5422-792X","observed_orcids":["https://orcid.org/0000-0001-5422-792X"]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshiko Tomita","raw_affiliation_strings":["Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan"],"raw_orcid":"https://orcid.org/0000-0001-5422-792X","affiliations":[{"raw_affiliation_string":"Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113448337","display_name":"Emma K. Hansson","orcid":"https://orcid.org/0009-0004-3053-588X","observed_orcids":["https://orcid.org/0009-0004-3053-588X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emma Hansson","raw_affiliation_strings":["Pharmetheus AB, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmetheus AB, Uppsala, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032561856","display_name":"Florent Mazuir","orcid":"https://orcid.org/0000-0003-2219-2181","observed_orcids":["https://orcid.org/0000-0003-2219-2181"]},"institutions":[{"id":"https://openalex.org/I4405267644","display_name":"Poxel SA (France)","ror":"https://ror.org/03qccw762","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405267644"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florent Mazuir","raw_affiliation_strings":["Poxel SA, Lyon, France"],"raw_orcid":"https://orcid.org/0000-0003-2219-2181","affiliations":[{"raw_affiliation_string":"Poxel SA, Lyon, France","institution_ids":["https://openalex.org/I4405267644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019595690","display_name":"Gustaf J. Wellhagen","orcid":"https://orcid.org/0000-0002-7228-0422","observed_orcids":["https://orcid.org/0000-0002-7228-0422"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gustaf J Wellhagen","raw_affiliation_strings":["Pharmetheus AB, Uppsala, Sweden"],"raw_orcid":"https://orcid.org/0000-0002-7228-0422","affiliations":[{"raw_affiliation_string":"Pharmetheus AB, Uppsala, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040606475","display_name":"Qing Xi Ooi","orcid":"https://orcid.org/0000-0003-4310-9842","observed_orcids":["https://orcid.org/0000-0003-4310-9842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qing Xi Ooi","raw_affiliation_strings":["Pharmetheus AB, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmetheus AB, Uppsala, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070494045","display_name":"Enrica Mezzalana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Enrica Mezzalana","raw_affiliation_strings":["Pharmetheus AB, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmetheus AB, Uppsala, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047891831","display_name":"Atsushi Kitamura","orcid":"https://orcid.org/0000-0003-0303-1198","observed_orcids":["https://orcid.org/0000-0003-0303-1198"]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsushi Kitamura","raw_affiliation_strings":["Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076600876","display_name":"Daisuke Nemoto","orcid":"https://orcid.org/0009-0000-1896-4260","observed_orcids":["https://orcid.org/0009-0000-1896-4260"]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Daisuke Nemoto","raw_affiliation_strings":["Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058953298","display_name":"S\u00e9bastien Bolze","orcid":"https://orcid.org/0000-0002-5122-1415","observed_orcids":["https://orcid.org/0000-0002-5122-1415"]},"institutions":[{"id":"https://openalex.org/I4405267644","display_name":"Poxel SA (France)","ror":"https://ror.org/03qccw762","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405267644"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S\u00e9bastien Bolze","raw_affiliation_strings":["Poxel SA, Lyon, France"],"raw_orcid":"https://orcid.org/0000-0002-5122-1415","affiliations":[{"raw_affiliation_string":"Poxel SA, Lyon, France","institution_ids":["https://openalex.org/I4405267644"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5050010032"],"corresponding_institution_ids":["https://openalex.org/I31591830"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":{"value":3300,"currency":"USD","value_usd":3300},"fwci":2.3969,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.88659596,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"15","issue":"4","first_page":"1014","last_page":"1026"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6416000127792358,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.6416000127792358,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.24500000476837158,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.04349999874830246,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imeglimin","display_name":"imeglimin","score":0.9639999866485596},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9399999976158142},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9649999737739563},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.8899999856948853},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.8299999833106995},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.9190000295639038},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.9139999747276306},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.503000020980835},{"id":"https://openalex.org/keywords/western-patients","display_name":"Western patients","score":0.8740000128746033},{"id":"https://openalex.org/keywords/pharmacokinetic-simulation","display_name":"pharmacokinetic simulation","score":0.6610000133514404},{"id":"https://openalex.org/keywords/relative-bioavailability","display_name":"relative bioavailability","score":0.671999990940094},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.4399999976158142},{"id":"https://openalex.org/keywords/dosing-interval","display_name":"dosing interval","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7964526414871216},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.7831745147705078},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6918878555297852},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6845750212669373},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.6425794363021851},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6050080060958862},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.530761182308197},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5247480869293213},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4613812565803528},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.45806342363357544},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.4571329355239868},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4499847888946533},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4481097459793091},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.4362657368183136},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.4339941143989563},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36604559421539307},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32418590784072876},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.30245327949523926},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/cts.13221","doi":"https://doi.org/10.1111/cts.13221","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13221","pdf_url":null,"source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9010270","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9010270/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9010270/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Transl Sci","raw_type":"Text"},{"id":"pmid:34962074","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34962074","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and translational science","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:3e3132820bcb4d2da779643ed7da92c4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3e3132820bcb4d2da779643ed7da92c4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Translational Science, Vol 15, Iss 4, Pp 1014-1026 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1111/cts.13221","doi":"https://doi.org/10.1111/cts.13221","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.13221","pdf_url":null,"source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200544627.pdf","grobid_xml":"https://content.openalex.org/works/W4200544627.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W44929223","https://openalex.org/W1965479467","https://openalex.org/W2011419421","https://openalex.org/W2025436379","https://openalex.org/W2042553471","https://openalex.org/W2058734479","https://openalex.org/W2066464642","https://openalex.org/W2125680719","https://openalex.org/W2146462191","https://openalex.org/W2149967041","https://openalex.org/W2152189242","https://openalex.org/W2155965977","https://openalex.org/W2201944786","https://openalex.org/W2467227824","https://openalex.org/W2607031541","https://openalex.org/W2797990830","https://openalex.org/W2894854793","https://openalex.org/W2974788498","https://openalex.org/W3007139901","https://openalex.org/W3009840064","https://openalex.org/W3015347220","https://openalex.org/W3081993672","https://openalex.org/W3091241000","https://openalex.org/W3091926099","https://openalex.org/W3101562859","https://openalex.org/W3108349261","https://openalex.org/W3109659757","https://openalex.org/W3127703453","https://openalex.org/W4200601117","https://openalex.org/W4255926242"],"related_works":["https://openalex.org/W4322496062","https://openalex.org/W4286433089","https://openalex.org/W4412907414","https://openalex.org/W2162492372","https://openalex.org/W2140536043","https://openalex.org/W4367175127","https://openalex.org/W3101761646","https://openalex.org/W3080701052","https://openalex.org/W2940474223","https://openalex.org/W3099057929"],"abstract_inverted_index":{"Abstract":[0],"Imeglimin":[1,56],"is":[2,16],"an":[3,77],"orally":[4],"administered":[5],"first\u2010in\u2010class":[6],"drug":[7],"to":[8,27,40,73,118],"treat":[9],"type":[10],"2":[11,88,169],"diabetes":[12],"mellitus":[13],"(T2DM)":[14],"and":[15,39,51,61,65,105,126,131,144,171,197,213,220,226],"mainly":[17,205],"excreted":[18],"unchanged":[19],"by":[20,139,207],"the":[21,29,42,106,148,154,201,211,215,233,245],"kidneys.":[22],"The":[23,121],"present":[24],"study":[25],"aimed":[26],"define":[28],"pharmacokinetic":[30],"(PK)":[31],"characteristics":[32],"of":[33,123,132,242,248],"imeglimin":[34,243],"using":[35,100],"population":[36,93,102,140],"PK":[37,94,96,103,141],"analysis":[38,117],"determine":[41],"optimal":[43],"dosing":[44,150,177],"regimen":[45,151],"for":[46,162,181],"Japanese":[47,60,196,225],"patients":[48,66,70,163,199],"with":[49,67,71,76,114,164,174,183,250],"T2DM":[50,249],"chronic":[52],"kidney":[53],"disease":[54],"(CKD).":[55],"plasma":[57,193,216],"concentrations":[58],"in":[59,91,192,210,224,232,244],"Western":[62,198,227],"healthy":[63],"volunteers,":[64],"T2DM,":[68],"including":[69],"mild":[72],"severe":[74],"CKD":[75],"estimated":[78],"glomerular":[79],"filtration":[80],"rate":[81],"(eGFR)":[82],"greater":[83],"than":[84,186],"14":[85],"ml/min/1.73":[86,167],"m":[87,168],"were":[89,98,137,204],"included":[90],"a":[92,101,175,208],"analysis.":[95,142],"simulations":[97],"conducted":[99],"model,":[104],"area":[107],"under":[108],"concentration\u2010time":[109],"curve":[110],"(AUC)":[111],"was":[112,156,179,230],"extrapolated":[113],"power":[115],"regression":[116],"lower":[119],"eGFR.":[120],"influence":[122],"eGFR,":[124],"weight,":[125],"age":[127],"on":[128,134,153],"apparent":[129],"clearance":[130],"dose":[133,203],"relative":[135],"bioavailability":[136],"quantified":[138],"Simulations":[143,188],"extrapolation":[145],"revealed":[146,189],"that":[147,190,214],"recommended":[149],"based":[152],"AUC":[155,217],"500":[157,172],"mg":[158,173,222],"twice":[159],"daily":[160],"(b.i.d.)":[161],"eGFR":[165,184,212],"15\u201345":[166],",":[170],"longer":[176],"interval":[178],"suggested":[180],"those":[182],"less":[185],"15.":[187],"differences":[191],"AUCs":[194],"between":[195],"at":[200],"same":[202],"driven":[206],"difference":[209],"after":[218],"1000":[219],"1500":[221],"b.i.d.":[223],"patients,":[228],"respectively,":[229],"comparable":[231],"phase":[234],"IIb":[235],"studies.":[236],"These":[237],"results":[238],"indicate":[239],"suitable":[240],"dosages":[241],"clinical":[246],"setting":[247],"renal":[251],"impairment.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-12-31T00:00:00"}